Detalhe da pesquisa
1.
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis.
Ann Hematol
; 99(12): 2821-2829, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32734548
2.
Consensus statement for cancer patients requiring intensive care support.
Ann Hematol
; 97(7): 1271-1282, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29704018
3.
[Rheumatoid symptoms in patients with hematologic neoplasms]. / Rheumatische Krankheitserscheinungen bei hämatologischen Neoplasien.
Z Rheumatol
; 76(Suppl 2): 38-45, 2017 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-29330756
4.
[Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU]. / Hämophagozytische Lymphohistiozytose : Diagnostische Herausforderung auf der ITS.
Anaesthesist
; 65(10): 776-786, 2016 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-27612865
5.
[Chronic myelogenous leukemia]. / Chronische myeloische Leukämie.
Internist (Berl)
; 56(4): 333-43, 2015 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-25860113
6.
Fulminant gastrointestinal bleeding caused by EBV-triggered hemophagocytic lymphohistiocytosis: report of a case.
Z Gastroenterol
; 52(4): 354-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24718941
7.
[Tailored management of chronic myeloid leukemia]. / Maßgeschneiderte Therapie der chronischen myeloischen Leukämie.
Internist (Berl)
; 54(2): 155-6, 158-60, 162-3, 2013 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-23371258
8.
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.
Leukemia
; 37(9): 1879-1886, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507425
9.
Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting.
Ann Hematol
; 91(11): 1765-72, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22926531
10.
[Hemophagocytic lymphohistiocytosis in critically ill patients]. / Die hämophagozytische Lymphohistiozytose bei kritisch kranken Patienten.
Med Klin Intensivmed Notfmed
; 116(2): 129-134, 2021 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-33580314
11.
[Interdisciplinary COVID board for patients with SARS-CoV-2-triggered hyperferritinemic Inflammation]. / Interdisziplinäres COVID-Board bei SARS-CoV-2-getriggerter hyperferritinämischer Inflammation.
Med Klin Intensivmed Notfmed
; 116(2): 138-145, 2021 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-33112981
12.
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.
Leukemia
; 34(7): 1805-1815, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32518419
13.
A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin's lymphoma.
J Cancer Res Clin Oncol
; 142(4): 845-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26660106
14.
The impact of specific cytokine directed treatment on severe COVID-19.
Leukemia
; 35(12): 3613-3615, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34493799
15.
[Erratum to: Interdisciplinary COVID board for patients with triggered hyperferritinemic Inflammation]. / Erratum zu: Interdisziplinäres COVID-Board bei SARS-CoV-2-getriggerter Hyperferritinämischer Inflammation.
Med Klin Intensivmed Notfmed
; 116(2): 145, 2021 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-33289864
16.
Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance.
Leukemia
; 18(8): 1321-31, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15215876
17.
Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective.
Leukemia
; 16(7): 1213-9, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12094245
18.
Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.
Leukemia
; 14(11): 2006-10, 2000 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-11069038
19.
Detection and quantification of residual disease in chronic myelogenous leukemia.
Leukemia
; 14(6): 998-1005, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10865964
20.
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.
Leukemia
; 16(11): 2190-6, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12399961